Human temporomandibular joint and myofascial pain biochemical profiles

A case-control study

D. L. Basi, A. M. Velly, E. L. Schiffman, P. A. Lenton, D. A. Besspiata, A. M. Rankin, Pamela Hughes, J. Q. Swift, L. J. Kehl

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Summary Neurobiological mechanisms of human musculoskeletal pain are poorly understood. This case-control study tested the hypothesis that biomarkers within temporomandibular muscle and joint disorders (TMJD) subjects' masseter muscles or temporomandibular joint (TMJ) synovial fluid correlate with plasma biomarker concentrations. Fifty subjects were recruited and categorized into TMJD cases (n=23) and pain-free controls (n=27) at the University of Minnesota School of Dentistry. Prior to specimen collection, pain intensity and pressure pain threshold masseter muscles and the TMJs were assessed. We collected venous blood; biopsied masseter muscle; and sampled TMJ synovial fluid on the subjects' side of maximum pain intensity. We assayed these tissues for the presence of nerve growth factor (NGF), bradykinin (BK), leukotreine B 4 (LTB 4) and prostaglandin E 2 (PGE 2), F 2-isoprostane (F 2I) and substance P (SP). The data was analyzed using Spearman Correlation Coefficients. We found that only plasma concentrations of bradykinin statistically correlated with synovial fluid concentrations (ρ=-0·48, P=0·005), but no association was found between pain intensities. The data suggests that biomarkers used to assess TMJD need to be acquired in a site-specific manner. We also discovered that F 2I concentrations were associated with muscle pain intensity and muscle pressure pain threshold (PTT) (β=0·4, 95%CI: 0·03-0·8) and joint PPT (β=0·4, 95%CI: 0·07-0·8) suggesting that muscle oxidative stress is involved in myofascial pain and that F 2-I may be a biomarker for myofascial pain.

Original languageEnglish (US)
Pages (from-to)326-337
Number of pages12
JournalJournal of Oral Rehabilitation
Volume39
Issue number5
DOIs
StatePublished - May 2012
Externally publishedYes

Fingerprint

Temporomandibular Joint
Arthralgia
Case-Control Studies
Masseter Muscle
Temporomandibular Joint Disorders
Synovial Fluid
Pain
Muscular Diseases
Biomarkers
Isoprostanes
Pain Threshold
Myalgia
Bradykinin
School Dentistry
Specimen Handling
Pressure
Musculoskeletal Pain
Nerve Growth Factor
Substance P
Prostaglandins E

Keywords

  • Biomarkers
  • Case-control study
  • Human
  • Mechanical injury
  • Musculoskeletal disorders
  • Myofascial pain
  • Neurogenic inflammation and oxidative stress
  • Temporomandibular joint

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Basi, D. L., Velly, A. M., Schiffman, E. L., Lenton, P. A., Besspiata, D. A., Rankin, A. M., ... Kehl, L. J. (2012). Human temporomandibular joint and myofascial pain biochemical profiles: A case-control study. Journal of Oral Rehabilitation, 39(5), 326-337. https://doi.org/10.1111/j.1365-2842.2011.02271.x

Human temporomandibular joint and myofascial pain biochemical profiles : A case-control study. / Basi, D. L.; Velly, A. M.; Schiffman, E. L.; Lenton, P. A.; Besspiata, D. A.; Rankin, A. M.; Hughes, Pamela; Swift, J. Q.; Kehl, L. J.

In: Journal of Oral Rehabilitation, Vol. 39, No. 5, 05.2012, p. 326-337.

Research output: Contribution to journalArticle

Basi, DL, Velly, AM, Schiffman, EL, Lenton, PA, Besspiata, DA, Rankin, AM, Hughes, P, Swift, JQ & Kehl, LJ 2012, 'Human temporomandibular joint and myofascial pain biochemical profiles: A case-control study', Journal of Oral Rehabilitation, vol. 39, no. 5, pp. 326-337. https://doi.org/10.1111/j.1365-2842.2011.02271.x
Basi, D. L. ; Velly, A. M. ; Schiffman, E. L. ; Lenton, P. A. ; Besspiata, D. A. ; Rankin, A. M. ; Hughes, Pamela ; Swift, J. Q. ; Kehl, L. J. / Human temporomandibular joint and myofascial pain biochemical profiles : A case-control study. In: Journal of Oral Rehabilitation. 2012 ; Vol. 39, No. 5. pp. 326-337.
@article{2ffa106651c741dc899f15ad80eb412b,
title = "Human temporomandibular joint and myofascial pain biochemical profiles: A case-control study",
abstract = "Summary Neurobiological mechanisms of human musculoskeletal pain are poorly understood. This case-control study tested the hypothesis that biomarkers within temporomandibular muscle and joint disorders (TMJD) subjects' masseter muscles or temporomandibular joint (TMJ) synovial fluid correlate with plasma biomarker concentrations. Fifty subjects were recruited and categorized into TMJD cases (n=23) and pain-free controls (n=27) at the University of Minnesota School of Dentistry. Prior to specimen collection, pain intensity and pressure pain threshold masseter muscles and the TMJs were assessed. We collected venous blood; biopsied masseter muscle; and sampled TMJ synovial fluid on the subjects' side of maximum pain intensity. We assayed these tissues for the presence of nerve growth factor (NGF), bradykinin (BK), leukotreine B 4 (LTB 4) and prostaglandin E 2 (PGE 2), F 2-isoprostane (F 2I) and substance P (SP). The data was analyzed using Spearman Correlation Coefficients. We found that only plasma concentrations of bradykinin statistically correlated with synovial fluid concentrations (ρ=-0·48, P=0·005), but no association was found between pain intensities. The data suggests that biomarkers used to assess TMJD need to be acquired in a site-specific manner. We also discovered that F 2I concentrations were associated with muscle pain intensity and muscle pressure pain threshold (PTT) (β=0·4, 95{\%}CI: 0·03-0·8) and joint PPT (β=0·4, 95{\%}CI: 0·07-0·8) suggesting that muscle oxidative stress is involved in myofascial pain and that F 2-I may be a biomarker for myofascial pain.",
keywords = "Biomarkers, Case-control study, Human, Mechanical injury, Musculoskeletal disorders, Myofascial pain, Neurogenic inflammation and oxidative stress, Temporomandibular joint",
author = "Basi, {D. L.} and Velly, {A. M.} and Schiffman, {E. L.} and Lenton, {P. A.} and Besspiata, {D. A.} and Rankin, {A. M.} and Pamela Hughes and Swift, {J. Q.} and Kehl, {L. J.}",
year = "2012",
month = "5",
doi = "10.1111/j.1365-2842.2011.02271.x",
language = "English (US)",
volume = "39",
pages = "326--337",
journal = "Journal of Oral Rehabilitation",
issn = "0305-182X",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Human temporomandibular joint and myofascial pain biochemical profiles

T2 - A case-control study

AU - Basi, D. L.

AU - Velly, A. M.

AU - Schiffman, E. L.

AU - Lenton, P. A.

AU - Besspiata, D. A.

AU - Rankin, A. M.

AU - Hughes, Pamela

AU - Swift, J. Q.

AU - Kehl, L. J.

PY - 2012/5

Y1 - 2012/5

N2 - Summary Neurobiological mechanisms of human musculoskeletal pain are poorly understood. This case-control study tested the hypothesis that biomarkers within temporomandibular muscle and joint disorders (TMJD) subjects' masseter muscles or temporomandibular joint (TMJ) synovial fluid correlate with plasma biomarker concentrations. Fifty subjects were recruited and categorized into TMJD cases (n=23) and pain-free controls (n=27) at the University of Minnesota School of Dentistry. Prior to specimen collection, pain intensity and pressure pain threshold masseter muscles and the TMJs were assessed. We collected venous blood; biopsied masseter muscle; and sampled TMJ synovial fluid on the subjects' side of maximum pain intensity. We assayed these tissues for the presence of nerve growth factor (NGF), bradykinin (BK), leukotreine B 4 (LTB 4) and prostaglandin E 2 (PGE 2), F 2-isoprostane (F 2I) and substance P (SP). The data was analyzed using Spearman Correlation Coefficients. We found that only plasma concentrations of bradykinin statistically correlated with synovial fluid concentrations (ρ=-0·48, P=0·005), but no association was found between pain intensities. The data suggests that biomarkers used to assess TMJD need to be acquired in a site-specific manner. We also discovered that F 2I concentrations were associated with muscle pain intensity and muscle pressure pain threshold (PTT) (β=0·4, 95%CI: 0·03-0·8) and joint PPT (β=0·4, 95%CI: 0·07-0·8) suggesting that muscle oxidative stress is involved in myofascial pain and that F 2-I may be a biomarker for myofascial pain.

AB - Summary Neurobiological mechanisms of human musculoskeletal pain are poorly understood. This case-control study tested the hypothesis that biomarkers within temporomandibular muscle and joint disorders (TMJD) subjects' masseter muscles or temporomandibular joint (TMJ) synovial fluid correlate with plasma biomarker concentrations. Fifty subjects were recruited and categorized into TMJD cases (n=23) and pain-free controls (n=27) at the University of Minnesota School of Dentistry. Prior to specimen collection, pain intensity and pressure pain threshold masseter muscles and the TMJs were assessed. We collected venous blood; biopsied masseter muscle; and sampled TMJ synovial fluid on the subjects' side of maximum pain intensity. We assayed these tissues for the presence of nerve growth factor (NGF), bradykinin (BK), leukotreine B 4 (LTB 4) and prostaglandin E 2 (PGE 2), F 2-isoprostane (F 2I) and substance P (SP). The data was analyzed using Spearman Correlation Coefficients. We found that only plasma concentrations of bradykinin statistically correlated with synovial fluid concentrations (ρ=-0·48, P=0·005), but no association was found between pain intensities. The data suggests that biomarkers used to assess TMJD need to be acquired in a site-specific manner. We also discovered that F 2I concentrations were associated with muscle pain intensity and muscle pressure pain threshold (PTT) (β=0·4, 95%CI: 0·03-0·8) and joint PPT (β=0·4, 95%CI: 0·07-0·8) suggesting that muscle oxidative stress is involved in myofascial pain and that F 2-I may be a biomarker for myofascial pain.

KW - Biomarkers

KW - Case-control study

KW - Human

KW - Mechanical injury

KW - Musculoskeletal disorders

KW - Myofascial pain

KW - Neurogenic inflammation and oxidative stress

KW - Temporomandibular joint

UR - http://www.scopus.com/inward/record.url?scp=84859563626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859563626&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2842.2011.02271.x

DO - 10.1111/j.1365-2842.2011.02271.x

M3 - Article

VL - 39

SP - 326

EP - 337

JO - Journal of Oral Rehabilitation

JF - Journal of Oral Rehabilitation

SN - 0305-182X

IS - 5

ER -